Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Acorda Therapeutics, Inc. (NQ: ACOR)
32.40 USD  +0.24 (+0.75%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Acorda Therapeutics, Inc.
 
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Acorda Therapeutics to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
February 15, 2011
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on February 17, 2011
February 10, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the 13th Annual BIO CEO & Investor Conference
February 07, 2011
from Business Wire News Releases
BestOfOTC.com Stocks to Eye on for (ACOR, MSFT, GOOG, BAC, EEM, AMD, AAPL, CHBT)
January 24, 2011
from EmailWire.Com Press Releases
Top Percentage Losers 1/21 (AMD, VVUS, JNY, ACOR) by EquityMarketReport.com
January 21, 2011
from EmailWire.Com Press Releases
BestOfOTC.com Stocks under Radar to watch at NASDAQ for (THOR, ACOR, CTRP, DRWI, BRKR, PSTI, AUXL, CNXT)
January 14, 2011
from EmailWire.Com Press Releases
BestOfOTC.com Stocks to Watch at NASDAQ: (BRKR, PSTI, SDIX, MU, NVDA, BODY, THOR, ACOR)
January 14, 2011
from EmailWire.Com Press Releases
BestOfOTC.com Stocks Under Radar at NASDAQ for (ACOR, AAPL, WAVX, APOL, DNDN, AVNT, STRA)
January 12, 2011
from EmailWire.Com Press Releases
Acorda Therapeutics To Provide Business Update Today at J.P. Morgan Healthcare Conference
January 10, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference
January 04, 2011
from Business Wire News Releases
EHSI: Celulas Genetica to Patent Breakthrough Stem Cell Treatment
December 09, 2010
from Business Wire News Releases
Acorda Therapeutics Announces Initiation of Phase 1 GGF2 Clinical Trial in Patients with Heart Failure
December 09, 2010
from Business Wire News Releases
Acorda Therapeutics to Present at the 2010 Deutsche Bank BioFEST Conference
December 07, 2010
from Business Wire News Releases
Equity Research on Amgen Inc. and Acorda Therapeutics Inc. - Sneak Peek in the Biotech Industry
December 02, 2010
from Marketwired News Releases
Acorda Therapeutics to Present at the J.P. Morgan SMid Cap Conference
November 24, 2010
from Business Wire News Releases
Acorda Therapeutics to Present at the 22nd Annual Piper Jaffray Health Care Conference
November 23, 2010
from Business Wire News Releases
Additional Phase 3 Clinical Trial Data Published in Annals of Neurology Showing Dalfampridine Extended Release Tablets Improved Walking Ability in People with Multiple Sclerosis
November 17, 2010
from Business Wire News Releases
Acorda Therapeutics to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
November 09, 2010
from Business Wire News Releases
Acorda Therapeutics Reports Third Quarter 2010 Financial Results
November 01, 2010
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report Third Quarter 2010 Financial Results on November 1, 2010
October 25, 2010
from Business Wire News Releases
Preclinical Studies Show GGF2 Promotes Functional Recovery from Stroke with Treatment Initiated Up to Seven Days After Event
October 19, 2010
from Business Wire News Releases
Preclinical Studies Show GGF2 Promotes Functional Recovery from Stroke with Treatment Initiated Up to Seven Days After Event
October 19, 2010
from Business Wire News Releases
Acorda Therapeutics to Present at the 17th Annual NewsMakers in the Biotech Industry Conference
October 18, 2010
from Business Wire News Releases
Acorda Therapeutics to Present at the 17th Annual NewsMakers in the Biotech Industry Conference
October 18, 2010
from Business Wire News Releases
Acorda Therapeutics Announces Data on AMPYRA® (dalfampridine) Presented at 26th Congress of European Committee for Treatment and Research in Multiple Sclerosis
October 15, 2010
from Business Wire News Releases
Acorda Therapeutics Announces Data on AMPYRA® (dalfampridine) Presented at 26th Congress of European Committee for Treatment and Research in Multiple Sclerosis
October 15, 2010
from Business Wire News Releases
Acorda Therapeutics to Present at the Fifth Annual JMP Securities Healthcare Conference
September 20, 2010
from Business Wire News Releases
Drug Manufacturers -- How Will Expiring Drug Patents Affect Companies in the Healthcare Sector
August 26, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by the BedfordReport.com Read More
from Marketwired News Releases
Acorda Therapeutics Reports Second Quarter 2010 Financial Results
August 03, 2010
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report Second Quarter 2010 Financial Results on August 3, 2010
July 27, 2010
from Business Wire News Releases
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here